Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson's Disease

Abstract

Background and Aim: Gut bacteria play an important role in the pathogenesis of Parkinson's disease (PD). However, the alteration of fecal microbiota in PD with cognitive impairment remains unexplored. This study aimed to explore whether the gut microbiota of patients with PD having mild cognitive impairment (PD-MCI) were different from those with PD having normal cognition (PD-NC) and from healthy controls (HC). Also, the study probed the association between altered gut microbiota and cognitive ability in patients with PD. Methods: The fecal bacteria composition and short-chain fatty acids of 13 patients with PD-MCI, 14 patients with PD-NC, and 13 healthy spouses were analyzed using 16S ribosomal RNA sequencing and gas chromatography-mass spectrometry. Results: Compared with HC, the fecal microbial diversities increased in patients with PD-MCI and PD-NC. After adjusting the influence of age, sex, body mass index, education, and constipation using the statistical method, the relative abundances of two families (Rikenellaceae and Ruminococcaceae) and four genera (Alistipes, Barnesiella, Butyricimonas, and Odoribacter) were found to be higher in the feces of the PD-MCI group compared with the other two groups. Moreover, the abundance of genus Blautia and Ruminococcus decreased obviously in the PD-MCI group compared with the PD-NC group. Further, the abundance of genera Butyricimonas, Barnesiella, Alistipes, Odoribacter, and Ruminococcus negatively correlated with cognition ability. Conclusion: Compared with HC and patients with PD-NC, the gut microbiota of patients with PD-MCI was significantly altered, particularly manifesting in enriched genera from Porphyromonadaceae family and decreased the abundance of genera Blautia and Ruminococcus.

Clinical Features and Gut Microbial Alterations in Anti-leucine-rich Glioma-Inactivated 1 Encephalitis—A Pilot Study

“…Further studies on members within this genus in anti-LGI1 encephalitis are needed. Recent studies have reported that some bacteria are associated with not only the onset of diseases but also with the certain clinical symptoms (40)(41)(42). Given the fact that the Sphingomonas genera increased in both anti-LGI1 encephalitis and Parkinson's disease, we made a bold assumption that the Sphingomonas may link to the extrapyramidal symptoms or even the pathomechanisms of FBDS.…”

A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson’s disease

“…This provides support for our hypothesis that gut-dysbiosis is associated with an altered neuroinflammatory response that increases susceptibility to various clinical features, including depression and anxiety. Indeed, evidence is mounting that gut-dysbiosis is associated with a wide-range of symptoms in PD, including motor symptom severity, REM behavior sleep disorder and cognitive impairment [4] , [33] , [34] , [35] . However, findings of the association between non-motor symptoms, inflammation and dysbiosis have been correlational, and caution against causal assumptions are appropriate.…”

Predictive Value of Gut Microbiome for Cognitive Impairment in Patients with Hypertension

“…A previous study has hinted that GM may be associated with hypertension [ 32 , 42 – 44 ]. In this study, higher abundances of TM7 and TM7-3 were found in HTNCI patients than in HTNnCI patients.…”